Cancer Research

Merck Serono Announces Initiation Of Phase II/III Clinical Trial Of Atacicept In Lupus Nephritis

information, please visit http://www.merckserono.net or http://www.merck.de Contacts: Merck Serono, 9 Chemin ...

Article - Anna Ohlden - Dec 13 2007 - 2:30am

Benefits Of Oral Xeloda Over Continuous Intravenous Chemotherapy Confirmed For Advanced Stomach Cancer

at ASCO 2006 (6.) Cunningham et al, NEJM 2008, Vol 358:36-46. For further information please contact ...

Article - Anna Ohlden - Jan 7 2008 - 9:31am

Researchers Aim To Prevent Global Prematurity And Stillbirths

Institute visit http://research.seattlechildrens.org/. Media Contact: Jennifer Seymour Children's ...

Article - Anna Ohlden - Feb 18 2008 - 6:30am

Cellectis Sues Precision BioSciences For Infringement Of Its Patents Concerning Meganuclease Technology

(http://www.cellectis.com) For further information please contact: Cellectis SA, Andre Choulika, PhD., Chief Executive ...

Article - Anna Ohlden - Mar 13 2008 - 4:30pm

Eribulin Mesylate Demonstrated Anti-Tumor Activity In Heavily Pretreated Patients With Advanced Breast Cancer

contact: Andrew Day, Communications Director, Eisai Europe Ltd, +44(0)208-600-1400, +44(0)7973-411-419 ...

Article - Anna Ohlden - May 16 2008 - 1:31am

Merck Serono And Bionomics Announce Multiple Sclerosis Development And Licensing Agreement

Full prescribing information for these products can be obtained by contacting the Company or visiting ...

Article - Anna Ohlden - Jun 18 2008 - 7:30am

NICE Issues Final Appraisal Determination (FAD) Which Recommends Baraclude(R) (Entecavir) As A Treatment Option For Eligible Chr

FAD, June 2008. For media enquiries contact: Caroline Almeida, Bristol-Myers Squibb, Tel: ...

Article - Anna Ohlden - Jun 24 2008 - 6:32pm

Silence Therapeutics Announces Successful Opposition Of Glover Patent

+44-0-20-7307-1620; or European Contacts, Citigate Dewe Rogerson, David Dible or Heather Keohane, +44-0-20-7638-9571; ...

Article - Anna Ohlden - Jul 11 2008 - 10:33am

Canopus Biopharma And Leading Chinese Researcher Team Up To Treat Avian Influenza, To Prevent Possible Pandemic

Securities and Exchange Commission Canopus BioPharma Inc Contact: Len Rothstein, President, Tel. ...

Article - Anna Ohlden - Aug 11 2008 - 6:32pm

New Research Reveals That Mycamine(R) Is An Effective Treatment In Children, Young Babies And Premature Infants

double-blind trial. Lancet 2007;369:1519-1527. For more information please contact: Mindy Dooa, Astellas Pharma ...

Article - Anna Ohlden - Aug 28 2008 - 12:33pm